MICALLEF JACOB VINCENT (Chief Scientific Officer) purchased 12.5% of their position (43.69K shares) of VOLITIONRX LTD on the open market
Open‑market purchase worth $25.0K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/10/2024ACC: 0001477932-24-007970
Officer· Chief Scientific Officer
+43.69K
Net shares
Net buyer
$25.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
43.69K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+43.69K
Price / share
$0.57
Trade value
$25K
% of position
12.5%
—
350.66K→394.35K
Total
Net shares
+43.69K
Net value
$25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | — | P · Purchase | +43.69K | $0.57 | $25K | 12.5% | 350.66K | 394.35K |
| Total | +43.69K | $25K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned38.11K
Common Stock
IndirectShares owned55K
Total
93.11K indirect93.11K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 38.11K | Indirect |
| Common Stock | 55K | Indirect |
| Total | 93.11K | 93.11K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported